At the 2015 American Society of Hematology (ASH) annual meeting, myeloma expert Dr. James Berenson joined Patient Power to discuss the recent wave of approvals for the treatment of multiple myeloma. Dr. Berenson speaks about the range of new therapies, discussing monoclonal antibodies, proteasome inhibitors and many others, including where each of these treatments fit into patient care. He also discusses potential issues with patient compliance, the cost of treatment and the path to cure.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo